Lehigh Valley Health NetworkLVHN Scholarly Works Research Scholars Poster Presentation The Impact of Web Based Education on Attitudes and Outcomes in Patients Taking Warfarin Sarah Rupp
Trang 1Lehigh Valley Health Network
LVHN Scholarly Works
Research Scholars Poster Presentation
The Impact of Web Based Education on Attitudes and Outcomes in Patients Taking Warfarin
Sarah Rupp
Rollins College
Kathryn Tadduni
Unversity of Pittsburgh
Follow this and additional works at: http://scholarlyworks.lvhn.org/research-scholars-posters
This Poster is brought to you for free and open access by LVHN Scholarly Works It has been accepted for inclusion in LVHN Scholarly Works by an authorized administrator For more information, please contact LibraryServices@lvhn.org
Published In/Presented At
Rupp, S.; Tadduni, K., (2015, July 31) The Impact of Web Based Education on Attitudes and Outcomes in Patients Taking Watfarin Poster
presented at LVHN Research Scholar Program Poster Session, Lehigh Valley Health Network, Allentown, PA.
Trang 2© 2014 Lehigh Valley Health Network
Lehigh Valley Health Network, Allentown, Pennsylvania
The Impact of Web Based Education on Attitudes and Outcomes in Patients Taking Warfarin
Patients taking warfarin are at risk for thromboembolic
events when not in a therapeutic international normalized
ratio (INR) range Patient’s lack of understanding
regarding their medication and illness often leads to
non-adherence to medication, which can lead to adverse
events In a retrospective cohort study, the Lehigh Valley
Physicians Group (LVPG) Anticoagulation Clinic will be
able to analyze the impact of implementing a web-based
educational application that can be accessed from the
patient’s home The objective is to educate warfarin-nạve
patients on their treatment in order to keep patients in a
therapeutic INR range and reduce the risk of adverse
events
To determine the impact of a web-based educational application on patients who are warfarin nạve compared to warfarin nạve patients who do not take part in the web based education
Outcomes captured and measured will include:
• Percent time patients remain in a therapeutic International
Normalized Ratio (INR) Range
Thrombosis (DVT), Pulmonary Embolism (PE), Myocardial Infarction (MI), and Number of hospitalizations and readmissions
• illness effects on Quality of Life (QoL) including the physical,
psychological, emotional, and spiritual impact
• Anxiety and Depression scores
• Patients knowledge and understanding of warfarin
• Patients Knowledge and understanding of their illness
The CHF cohort will be measured separately to determine the impact
of the community care team on patient outcomes
In a retrospective cohort study, Lehigh Valley Physicians Group (LVPG)
Anticoagulation Clinic will provide access to web-based education to patients
requiring first time treatment with the oral anticoagulant, warfarin These
patients will be followed for one year to capture % time in therapeutic range
and the frequency of adverse events such as stroke, gastrointestinal bleed,
deep vein thrombosis (DVT), pulmonary embolus (PE), myocardial infarction
(MI), hospital re-admissions, and hospitalizations Patient outcomes in the
study group will be compared to outcomes in warfarin nạve patents who do
not take part in the web-based education
Secondary outcomes will include patients’ perception on their quality of life,
severity of anxiety and depression, their knowledge regarding understanding
of their illness and medication prior to and after education Surveys will be
captured at baseline and six months Surveys include the Palliative Outcome
Scale (POS), to measure quality of life, Patient Health Questionnaire (PHQ-9)
to assess their depression score, Generalized Anxiety Disorder 7 Item Scale
(GAD-7) to assess their anxiety score, and Patient Activation Measure
(PAM) which will measure the patient’s knowledge and perception of both
their medication and illness
A community care team (CCT) will be joining LVPG Cardiology to assist with
the management of patients with Congestive Heart Failure (CHF).Team
members will be consulted when patients are identified in the study as having
anxiety, depression, poor coping skills, a poor understanding of their warfarin
medication, financial issues, or lack of social support at home These patient
outcomes will be analyzed separately to determine effectiveness of the CCT
on this patient population
Both the web-based education and the CCT installment
in the LVPG Anticoagulation Clinic aim to decrease overall hospital admissions and readmissions thereby cutting costs and satisfying the requirements for the Hospital Readmission Reduction Program under the Affordable Care Act With the objective of decreasing adverse events, keeping patients in a therapeutic INR range, and encouraging patients to be proactive and knowledgeable in regards to their treatment, both the web-based education and CCT have the intention of
achieving the three goals specified by the Triple Aim;
better cost, better health, and better care
Sarah Rupp, Kathryn Tadduni, Kay Werhun, DNP, MBA, RN, NE-BC, Valerie Rupp, MSN, RN, CRNP, Population Health
Introduction
Methodology
Objectives
Conclusion
Community Care Team
Behavioral Health
Specialist
Pharmacist
Social Worker
Nurse Care Manager
1
The Basics
of Taking Warfarin Module
Managing
Your Medications Module
Monitoring Warfarin Module
What Can Affect Warfarin Module
How To Stay Safe While Taking Warfarin
Admission Emergency Readmission Pre-Engagement 3731 1400 736 Post-Engagement 1932 1075 618 Patient Count (Not Unique) 1730 1022 721
0 200 400 600 800 1000 1200 1400 1600 1800 2000
0 500 1000 1500 2000 2500 3000 3500 4000
Community Care Team Utilization Data: All Practices
6 Months Pre & Post Intervention July 2012 through February 2015
Figure 1 Web-Based Education Modules
Figure 2 Patient Outcomes After Community Care Team Intervention
Figure 3 Members of a Community Care Team
References
Patient-Centered Medical Homes with Community Care Teams: Findings from a Pilot Study JCOM,
21(8)
intervention on patients’ knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and
outcome of Treatment with warfarin (TREAT) BMC Cardiovascular Disorders, 10(1), 21